Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Catherine O'Neal, MD, an infectious disease physician, took to the podium of the Louisiana governor's press conference on July 16 and did not mince words.
"The delta variant is not last year's virus, and it's become incredibly apparent to healthcare workers that we are dealing with a different beast," she said.
Louisiana is one of the least vaccinated states in the country. In the United States as a whole, 48.6% of the population is fully vaccinated. In Louisiana, it's just 36%, and Delta is bearing down.
O'Neal spoke about the pressure that rising COVID cases were already putting on her hospital, Our Lady of the Lake Regional Medical Center in Baton Rouge. She talked about watching her peers, 30- and 40-year-olds, become severely ill with the latest iteration of the new coronavirus — the Delta variant — which is sweeping through the United States with astonishing speed, causing new cases, hospitalizations, and deaths to rise again.
O'Neal talked about parents who might not be alive to see their children go off to college in a few weeks. She talked about increasing hospital admissions for infected kids and pregnant women on ventilators.
"I want to be clear after seeing what we've seen the last two weeks. We only have two choices: We are either going to get vaccinated and end the pandemic, or we're going to accept death and a lot of it," O'Neal said, her voice choked by emotion.
Where Delta Goes, Death Follows
Delta was first identified in India, where it caused a devastating surge in the spring. In a population that was largely unvaccinated, researchers think it may have caused as many as three million deaths. In just a few months' time, it has sped across the globe.
Research from the United Kingdom shows that Delta is highly contagious. It's about 60% more easily passed from person to person than the Alpha version (or B.1.1.7, which was first identified in the United Kingdom).
Where a single infected person might have spread older versions of the virus to two or three others, mathematician and epidemiologist Adam Kucharski, PhD, an associate professor at the London School of Hygiene and Tropical Medicine, thinks that number — called the basic reproduction number — might be around six for Delta, meaning that, on average, each infected person spreads the virus to six others.
"The delta variant is the most able and fastest and fittest of those viruses," said Mike Ryan, executive director of the World Health Organization's Health Emergencies Programme, in a recent press briefing.
Early evidence suggests it may also cause more severe disease in people who are not vaccinated.
"There's clearly increased risk of ICU admission, hospitalization, and death," said Ashleigh Tuite, PhD, MPH, an infectious disease epidemiologist at the University of Toronto in Ontario.
In a study published ahead of peer review, Tuite and her coauthor, David Fisman, MD, MPH, reviewed the health outcomes for more than 200,000 people who tested positive for SARS-CoV-2 in Ontario between February and June of 2021. Starting in February, Ontario began screening all positive COVID tests for mutations in the N501Y region for signs of mutation.
Compared with versions of the coronavirus that circulated in 2020, having an alpha, beta, or gamma variant modestly increased the odds that an infected person would become seriously ill with COVID. The delta variant raised the risk even higher, increasing the odds that an infected person would need to be hospitalized or could die from their infection by 50% compared to older variants, regardless of their vaccination status.
Emerging evidence from England and Scotland, analyzed by Public Health England, also shows an increased risk for hospitalization with Delta. The increases are in line with the Canadian data. Experts caution that the picture may change over time as more evidence is gathered.
"What is causing that? We don't know," Tuite said.
The Delta variants (there's actually more than one in the same viral family), have about 15 different mutations compared with the original virus. Two of these, L452R and E484Q, are mutations to the spike protein that were first flagged as problematic in other variants because they appear to help the virus escape the antibodies we make to fight it.
It has another mutation away from its binding site that's also getting researchers' attention — P681R.
This mutation appears to enhance the "springiness" of the parts of the virus that dock onto our cells, said Alexander Greninger, MD, PhD, assistant director of the UW Medicine Clinical Virology Laboratory at the University of Washington in Seattle. So it's more likely to be in the right position to infect our cells if we come into contact with it.
Another theory is that P681R may also enhance the virus's ability to fuse cells together into clumps that have several different nuclei. These balls of fused cells are called syncytia.
"So it turns into a big factory for making viruses," said Kamran Kadkhoda, PhD, medical director of immunopathology at the Cleveland Clinic in Ohio.
This capability is not unique to Delta or even to the new coronavirus. Earlier versions and other viruses can do the same thing, but according to a recent paper in Nature, the syncytia that Delta creates are larger than the ones created by previous variants.
Scientists aren't sure what these supersized syncytia mean, exactly, but they have some theories. They may help the virus copy itself more quickly, so a person's viral load builds up quickly. That may enhance the ability of the virus to transmit from person to person.
And at least one recent study from China supports this idea. That study, which was posted ahead of peer review on the website Virological.org, tracked 167 people infected with Delta back to a single index case.
China has used extensive contact tracing to identify people that may have been exposed to the virus and sequester them quickly to tamp down its spread. Once a person is isolated or quarantined, they are tested daily with gold-standard PCR testing to determine whether or not they were infected.
Researchers compared the characteristics of Delta cases with those of people infected in 2020 with previous versions of the virus.
This study found that people infected by Delta tested positive more quickly than their predecessors did. In 2020, it took an average of 6 days for someone to test positive after an exposure. With Delta, it took an average of about 4 days.
When people tested positive, they had more than 1000 times more virus in their bodies, suggesting that the Delta variant has a higher growth rate in the body.
This gives Delta a big advantage. According to Angie Rasmussen, PhD, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada, who posted a thread about the study on Twitter, if people are shedding 1000 times more virus, it's much more likely that close contacts will be exposed to enough of it to become infected themselves.
And if they're shedding earlier in the course of their infections, the virus has more opportunity to spread.
This may help explain why Delta is so much more contagious.
Beyond transmission, Delta's ability to form syncytia may have two other important consequences. It may help the virus hide from our immune system, and it may make the virus more damaging to the body.
Commonly, when a virus infects a cell, it will corrupt the cell's protein-making machinery to crank out more copies of itself. When the cell dies, these new copies are released into the plasma outside the cell where they can float over and infect new cells. It's in this extracellular space where a virus can also be attacked by the neutralizing antibodies our immune system makes to fight it off.
"Antibodies don't penetrate inside the cell. If these viruses are going from one cell to another by just fusing to each other, antibodies become less useful," Kadkhoda said.
Recent studies show that Delta is also able to escape antibodies made in response to vaccination more effectively than the Alpha, or B.1.1.7 strain. The effect was more pronounced in older adults, who tend to have weaker responses to vaccines in general.
This evasion of the immune system is particularly problematic for people who are only partially vaccinated. Data from the United Kingdom show that a single dose of vaccine is only about 31% effective at preventing illness with Delta, and 75% effective at preventing hospitalization.
After two doses, the vaccines are still highly effective — even against Delta — reaching 80% protection for illness, and 94% for hospitalization, which is why US officials are begging people to get both doses of their shots, and do it as quickly as possible.
Finally, the virus's ability to form syncytia may leave greater damage behind in the body's tissues and organs.
"Especially in the lungs," Kadkhoda said. The lungs are very fragile tissues. Their tiny air sacs — the alveoli — are only a single-cell thick. They have to be very thin to exchange oxygen in the blood.
"Any damage like that can severely affect any oxygen exchange and the normal housekeeping activities of that tissue," he said. "In those vital organs, it may be very problematic."
The research is still early, but studies in animals and cell lines are backing up what doctors say they are seeing in hospitalized patients.
A recent preprint study from researchers in Japan found that hamsters infected with Delta lost more weight — a proxy for how sick they were — compared with hamsters infected with an older version of the virus. The researchers attribute this to the viruses' ability to fuse cells together to form syncytia.
Another investigation, from researchers in India, infected two groups of hamsters — one with the original "wild type" strain of the virus, the other with the Delta variant of the new coronavirus.
As in the Japanese study, the hamsters infected with Delta lost more weight. When the researchers performed necropsies on the animals, they found more lung damage and bleeding in hamsters infected with Delta. This study was also posted as a preprint ahead of peer review.
German researchers working with pseudotyped versions of the new coronavirus — viruses that have been genetically changed to make them safer to work with — watched what happened after they used these pseudoviruses to infect lung, colon, and kidney cells in the lab.
They, too, found that cells infected with the Delta variant formed more and larger syncytia compared with cells infected with the wild type strain of the virus. The authors write that their findings suggest Delta could "cause more tissue damage, and thus be more pathogenic, than previous variants."
Researchers say it's important to remember that, while interesting, this research isn't conclusive. Hamsters and cells aren't humans. More studies are needed to prove these theories.
Scientists say that what we already know about Delta makes vaccination more important than ever.
"The net effect is really that, you know, this is worrisome in people who are unvaccinated and then people who have breakthrough infections, but it's not…a reason to panic or to throw up our hands and say you know, this pandemic is never going to end," Tuite said, "[b]ecause what we do see is that the vaccines continue to be highly protective."
Follow Brenda on Twitter: @ReporterGoodman.
Medscape Medical News © 2021
Cite this: 'Dealing With a Different Beast': Why Delta Has Doctors Worried - Medscape - Jul 20, 2021.